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E-mail address: wada@cc.mech.tohoku.ac.jp (H. WPrestin is a key molecule for mammalian hearing. The present study investigated changes in char-
acteristics of prestin by culturing prestin-transfected cells with salicylate, an antagonist of prestin.
As a result, the plasma membrane localization of prestin bearing a mutation in the GTSRH sequence,
which normally accumulates in the cytoplasm, was recovered. Moreover, the nonlinear capacitance
of the majority of the mutants, which is a signature of prestin activity, was also recovered. Thus, the
present study discovered a new effect of salicylate on prestin, namely, the promotion of the plasma
membrane expression of prestin mutants in an active state.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The motor protein prestin in the plasma membrane of co-
chlear outer hair cells (OHCs) is believed to be the origin of their
electromotility [1]. So far, several characteristics of prestin have
been clariﬁed by introduction of mutations into prestin [2].
Mutations in membrane proteins sometimes cause the accumula-
tion of these proteins in the cytoplasm. It has been reported that
when the cells expressing such accumulated mutants were cul-
tured with a pharmacological chaperone, which is a cell mem-
brane-permeable molecule with high afﬁnity for these mutants,
the chaperone bound to them and promoted their transport to
the plasma membrane in an active state [3–7]. Salicylate, which
is known as an antagonist of prestin, is thought to have cell
membrane permeability with high afﬁnity for prestin [8,9]. Thus,chemical Societies. Published by E
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agglutinin
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ada).salicylate was considered to be a candidate molecule to work as a
pharmacological chaperone for prestin. In the present study, the
aim was to investigate whether or not salicylate has the ability
to promote the plasma membrane expression of prestin mutants
accumulated in the cytoplasm.2. Materials and methods
2.1. Prestin mutants
Our previous study showed that mutations in the GTSRH se-
quence at positions 127–131 of prestin caused a decrease in non-
linear capacitance (NLC), which is a signature of prestin activity
[10]. Such decrease may be due to the accumulation of prestin
in the cytoplasm. Thus, the present study used the prestin
mutants created in our previous study, namely, G127A, T128A,
S129A, R130A, H131A and S129T. These mutants were engi-
neered to be expressed in HEK293 cells by transfection. As the
prestin genes were co-transfected with green ﬂuorescent protein
(GFP) gene into the cells, transfected cells were selected by GFP
observation.lsevier B.V. All rights reserved.
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Transfected cells were cultured with salicylate, which is gener-
ally known to have the ability to suppress NLC as an antagonist of
prestin, to conﬁrm another effect of salicylate as a pharmacological
chaperon for prestin. It was reported that, in the patch-clamp
recording, 10 mM salicylate around the cells was required for al-
most complete suppression of NLC, which might be realized by
the binding of salicylate with prestin in the plasma membrane
[9]. Thus, for the binding of salicylate with prestin, at least
10 mM salicylate was considered to be necessary. Although salicy-
late possibly affects the cell viability, it has been reported that
more than 85% of HEK293 cells were able to survive in the presence
of up to 10 mM sodium salicylate [11]. In the present study, the
cells were cultured for 24-36 hours in growth medium withFig. 1. Representative immunoﬂuorescence images of transfected cells. (A) Stained cells
Red and green ﬂuorescence show prestin and both the plasma membrane and Golgi bodi
localization of prestin and the plasma membrane, and that of prestin and the Golgi bodsodium salicylate at a concentration of 10 mM from 12 hours after
transfection. After such incubation, the cells were used in experi-
ments. The cells cultured without salicylate were employed as con-
trol samples. Samples of the cells expressing wild-type (WT)
prestin and its mutants which were cultured with 10 mM salicylate
were termed WT prestin+Sal, G127A+Sal, T128A+Sal, S129A+Sal,
R130A+Sal, H131A+Sal and S129T+Sal.
2.3. Conﬁrmation of the localization of prestin in transfected cells
The localization of prestin in the cells was assessed by immuno-
ﬂuorescence staining with anti-FLAG antibody, TRITC-conjugated
anti-mouse IgG antibody and wheat germ agglutinin (WGA)-Alexa
Fluor 633 conjugate as described in our previous study [12]. In the
present study, several tens of transfected cells were observed forcultured without 10 mM salicylate. (B) Stained cells cultured with 10 mM salicylate.
es, respectively. In the merged images, yellow–orange ﬂuorescence indicates the co-
ies.
Fig. 2. Rp of WT prestin and its mutants. The Rp values of all prestin mutants were statistically lower than that of WT prestin when salicylate was not used, but they were
increased by 10 mM salicylate. Asterisks show the statistical differences in the Rp values between WT prestin and the prestin mutants and between WT prestin+Sal and the
prestin mutants+Sal (p < 0.05). Number signs indicate statistical differences between Rp values obtained from cells cultured with salicylate and those obtained from cells
cultured without it in each prestin mutant (p < 0.05). Error bars show standard deviations.
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plasma membrane to the total amount of prestin in the cell, Rp,
was investigated. Rp was calculated by the following equation:
Rp ¼ IpIw ; ð1Þ
where Iw is the sum of the intensity values of TRITC ﬂuorescence of
the whole area of the target cell which reﬂects the total amount of
prestin in the cell, and Ip is the sum of the intensity values of TRITC
ﬂuorescence of only the pixels corresponding to the plasma mem-
brane, which reﬂects the amount of prestin there. The Iw and Ip were
calculated as described in our previous study [12].
2.4. Evaluation of electrophysiological properties of prestin
NLC, which is generally used for the analysis of prestin activity,
was measured in the whole-cell patch-clamp recording as de-
scribed in our previous study [13]. Transfected cells were washed
just before the recording. By such washing, salicylate bound to
prestin in the plasma membrane was expected to be dissociated
[9]. The cells without membrane disruption which showed robust
GFP ﬂuorescence were selected for measurement. The recorded
membrane capacitance was ﬁtted with the ﬁrst derivative of the
Boltzmann function [14],
CmðVÞ ¼ Clin þ Qmax
ae
VV1=2
a 1þ e
VV1=2
a
 2 ; ð2Þ
where Clin is the linear capacitance, which is proportional to the
membrane area of the cells, Qmax is the maximum charge transfer,
V is the membrane potential and V1/2 is the voltage at half-maximal
charge transfer. In Eq. (2), a is the slope factor of the voltage-depen-
dent charge transfer and is given by
a ¼ kT=ze; ð3Þ
where k is Boltzmann’s constant, T is absolute temperature, z is
valence and e is electron charge. To evaluate the maximum
charge transfer of prestin in the unit plasma membrane, Qmax,
which means the maximum charge transfer of prestin in whole
plasma membrane, was divided by Clin and designated as charge
density.
For the comparison of NLC curve, NLC had to be normalized by
the area of the plasma membrane. The normalized NLC Cnonlin/lin
was deﬁned asCnonlin=linðVÞ ¼ CnonlinClin ¼
ðCmðVÞ  ClinÞ
Clin
; ð4Þ
where Cnonlin is the nonlinear component of the measured mem-
brane capacitance.
2.5. Concentration dependence of effects of salicylate on prestin
The relationship between the concentration of salicylate and
the degree of the promotion of the plasma membrane expression
of prestin mutants was investigated. The cells transfected with
R130A were cultured with sodium salicylate at concentrations of
1 mM and 5 mM from 12 h after transfection. By the above-men-
tioned method, after 24 h of incubation, the cells were subjected
to immunoﬂuorescence staining and the Rp was then calculated.
3. Results and discussion
3.1. Localization of prestin in transfected cells
Representative immunoﬂuorescence images of stained cells
which were cultured without and with 10 mM salicylate are shown
in Fig. 1A and B, respectively. To statistically investigate the local-
ization of prestin in the cells, the Rp was calculated and shown in
Fig. 2. Without salicylate, the RP values of the prestin mutants were
statistically lower than that of WT prestin (p < 0.05), suggesting
that those mutants were accumulated in the cytoplasm. To conﬁrm
whether or not salicylate has the ability to promote the plasma
membrane expression of the prestin mutants, prestin-transfected
cells were cultured with 10 mM salicylate. The Rp of WT prestin
was unchanged by 10 mM salicylate, indicating that such amount
of salicylate did not affect the process of transport of WT prestin
to the plasma membrane (Fig. 2). On the other hand, the RP values
of all prestin mutants statistically increased, compared with those
when salicylate was not used (p < 0.05). Especially, the Rp of
G127A+Sal and that of R130A+Sal were similar to that of WT pres-
tin+Sal. These results indicate that salicylate promoted the plasma
membrane expression of the prestin mutants accumulated in the
cytoplasm.
3.2. Electrophysiological properties of prestin
The Cnonlin/lin (V), and charge density and a of WT prestin and
its mutants are shown in Figs. 3 and 4, respectively. Without
Fig. 3. Effects of salicylate on Cnonlin/lin of prestin. Filled circles and thick lines show the results of transfected cells cultured without salicylate, while open circles and thin lines
indicate the results of transfected cells cultured with 10 mM salicylate. (A) WT prestin and WT prestin+Sal. (B) G127A and G127A+Sal. (C) T128A and T128A+Sal. (D) S129A
and S129A+Sal. (E) R130A and R130A+Sal. (F) H131A and H131A+Sal. (G) S129T and S129T+Sal. (H) Empty and Empty+Sal. When salicylate was used, NLC of G127A, T128A,
S129A or R130A increased. On the other hand, in the case of H131A and S129T, NLC could not be detected in either type of cell, namely, cells cultured with and without 10 mM
salicylate.
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although their charge density was statistically smaller than that
of WT prestin. On the other hand, H131A and S129T did not showNLC. The charge density of WT prestin+Sal was similar to that of
WT prestin, suggesting that salicylate did not affect WT prestin it-
self nor the properties of the cells involved in the function of
Fig. 4. Changes in the charge density and a of prestin by salicylate. (A) Charge density. The charge density of WT prestin was not affected by salicylate. On the other hand, the
charge densities of G127A+Sal, T128A+Sal, S129A+Sal and R130A+Sal were statistically larger than those of G127A, T128A, S129A and R130A, respectively. (B) a. Without
salicylate, the a values of G127A, T128A, S129A and R130A were statistically different from that of WT prestin. On the other hand, when 10 mM salicylate was used, there was
no statistical difference in the a between the prestin mutants and WT prestin. Asterisks show the statistical differences in the charge density and a between WT prestin and
the prestin mutants and between WT prestin+Sal and the prestin mutants+Sal (p < 0.05). Number signs indicate statistical differences in the charge density and a between
cells cultured with salicylate and those cultured without it in each prestin mutant (p < 0.05). Error bars represent standard deviations.
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T128A+Sal, S129A+Sal and R130A+Sal were statistically larger
than those of G127A, T128A, S129A and R130A, respectively
(p < 0.05). Especially, the charge density of G127A+Sal and that
of R130A+Sal were similar to that of WT prestin+Sal. These results
indicate that the charge density of those four mutants was recov-
ered due to salicylate. On the other hand, H131A and S129T did
not show NLC even when transfected cells were cultured with
10 mM salicylate.
The a was considered to represent properties of the anion bind-
ing of prestin [15]. Such values of G127A, T128A, S129A and R130A
were statistically different from that of WT prestin when salicylate
was not used (Fig. 4). On the other hand, when transfected cells
were cultured with 10 mM salicylate, there was no statistical dif-
ference in a between the prestin mutants and WT prestin
(Fig. 4). These results may imply that culturing the cells with salic-
ylate somehow affects the properties of the anion binding of
prestin.
3.3. Correlation between the Rp and the charge density
Without salicylate, the Rp values of all prestin mutants were
lower than that of WT prestin. In this condition, the charge density
of the prestin mutants was also lower or not recorded. On the other
hand, salicylate increased both Rp and the charge density of G127A,
T128A, S129A and R130A. Especially in G127A and R130A, Rp as
well as the charge density recovered to the WT prestin level. This
trend suggests that the changes in the charge density were corre-
lated with changes in the RP. Although Rp increased to some degree
due to the addition of salicylate, H131A and S129T did not showNLC, possibly indicating that the amount of those mutants in the
plasma membrane was still insufﬁcient for detection of NLC. An-
other possibility is that H131A and S129T were promoted to be ex-
pressed in the plasma membrane but were non-functional.
Regarding S129A and S129T, the replacement of Ser-129 by
threonine affected both the Rp and the charge density of prestin
more strongly than that by alanine. Alanine and threonine are,
respectively, smaller and larger than serine. Thus, the existence
of an amino acid larger than serine at position 129 of prestin
may be a steric constraint, affecting its characteristics signiﬁcantly.
3.4. Changes in the concentration of salicylate
Salicylate at the concentration of 10 mM was found to recover
the plasma membrane expression and the charge density of
G127A and R130A to the WT prestin level as described above. Ef-
fects of decreasing the concentration of salicylate from 10 mM to
5 mM and 1 mM on the promotion of the plasma membrane
expression were then evaluated using the cells transfected with
R130A. Confocal images of the stained cells and calculated Rp are
shown in Fig. 5A and B, respectively. The Rp of R130A was un-
changed by 1 mM salicylate, while it was increased by 5 mM salic-
ylate but not to the WT prestin level, suggesting that the
promotion by salicylate of the plasma membrane expression of
prestin mutants was concentration-dependent.
3.5. Discovery of new effect of salicylate on prestin
Salicylate is generally known to be an antagonist of prestin
[8,9]. In the present study, another feature of salicylate was
Fig. 5. Concentration dependence of the effects of salicylate on the localization of
prestin. (A) Confocal microscopy images of stained cells. (B) Difference in the Rp due
to the difference in the concentration of salicylate. The samples of R130A-
expressing cells cultured without salicylate, with 1 mM salicylate, with 5 mM
salicylate and with 10 mM salicylate are termed R130A, R130A+Sal (1 mM),
R130A+Sal (5 mM) and R130A+Sal (10 mM), respectively, in this ﬁgure. In addition,
the samples of WT prestin-expressing cells cultured without salicylate and with
10 mM salicylate are termed WT prestin and WT prestin+Sal (10 mM), respectively.
The Rp of R130A was unchanged by 1 mM salicylate, but was increased by 5 mM
salicylate. When transfected cells were cultured with 10 mM salicylate, the Rp
recovered to the WT prestin level. Asterisks represent signiﬁcance vs. WT
prestin+Sal (10 mM) (p < 0.05). Error bars indicate standard deviations.
2332 S. Kumano et al. / FEBS Letters 584 (2010) 2327–2332discovered, namely, it can promote the plasma membrane
expression of prestin mutants accumulated in the cytoplasm,
resulting in the recovery of the charge density. Various research
ﬁndings have reported that if membrane proteins were accumu-
lated in the cytoplasm due to their misfolding, a pharmacological
chaperone bound to these proteins and then promoted their cor-
rect folding, resulting in their plasma membrane expression [3–
7]. These reports may lead to a speculation that the prestin mu-
tants analyzed in the present study were misfolded in the cyto-
plasm and that salicylate bound to these mutants and then
induced their correct folding, promoting their transport to theplasma membrane. The next step of our study is to clarify if such
speculation is correct, namely, to investigate the mechanism
underlying the salicylate-induced recovery of the plasma mem-
brane expression of prestin mutants.
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